The challenge of HTLV-1 therapeutics: lessons from anti-protease approaches. [PDF]
Ahmadi Ghezeldasht S +4 more
europepmc +1 more source
From serologic uncertainty to diagnostic clarity in unusual adult T-cell leukemia/lymphoma via HBZ in situ hybridization. [PDF]
Cheverez-Ocasio J +2 more
europepmc +1 more source
Therapeutic Approaches for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: Current and Emerging Strategies. [PDF]
Nakamura T, Satoh K.
europepmc +1 more source
HTLV-1 Tax and HBZ cooperatively promote leukemogenesis through miR-155-mediated PTEN suppression and PI3K-Akt activation. [PDF]
Xin X +5 more
europepmc +1 more source
No Evidence of HTLV-II Infection Among Immonoblot Indeterminate Samples Using Nested PCR in Mashhad, Northeast of Iran [PDF]
Houshang Rafatpanah +10 more
doaj
The m<sup>6</sup>A reader protein YTHDF2 facilitates HTLV-1 infectious and mitotic propagation by stabilizing Tax RNA. [PDF]
Liang Y +11 more
europepmc +1 more source
Seroprevalence Assessment of HTLV-1 and Its Related Risk Factors in Patients With Rheumatoid Arthritis in Gonabad in 2023. [PDF]
Tehranian F +3 more
europepmc +1 more source
Heterogeneity of HTLV-1 proviral integration sites and internal structures in the ATL cell line MT-1. [PDF]
Izaki M +4 more
europepmc +1 more source
Whole Blood Volume-Based Absolute Quantification of HTLV-1 Proviral Load: A Comparative Method Evaluation Study. [PDF]
Franco GO +4 more
europepmc +1 more source
Loss of HTLV-1-specific CD8<sup>+</sup> T-cell immunity in virus carriers predisposed to adult T-cell leukemia/lymphoma. [PDF]
Weterings DA +7 more
europepmc +1 more source

